T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis

Upregulation of genes for interferon (IFN)-&ggr; and CXC chemokine receptor (CXCR)3 expression, two crucial molecules in sarcoid inflammation and granuloma formation, is directly controlled by the T-helper (Th)1 transcription factor T-bet (T-box, expressed in T-cells). However, there is no information on T-bet expression in sarcoidosis or its relationship with “sarcoidosis-associated” genes. Therefore, we investigated expression of T-bet mRNA and, in parallel, a spectrum of genes known to be involved in sarcoidosis pathogenesis. Transcripts were determined in bronchoalveolar lavage (BAL) cells from 62 sarcoidosis patients and 25 controls by quantitative RT-PCR; T-bet protein was localised by immunohistochemistry. Patient’s BAL cells expressed higher mRNA T-bet levels than those of controls (mean±sd fold change 3.64±1.72; p=0.00006). T-bet mRNA expression did not vary between clinical phenotypes as assessed by chest radiography stage, presence/absence of Löfgren's syndrome, extrapulmonary/pulmonary involvement or progressing/remitting disease (p>0.05). T-bet mRNA expression correlated with expression of IFN-&ggr;, CC chemokine ligand 5, CXC chemokine ligand (CXC)10, interleukin (IL)-2 receptor/IL-15 receptor &bgr;, CXCR3 and CXCR6 (p<0.01). T-bet protein was localised to alveolar macrophages and lymphocytes, tissue multinucleated giant cells, macrophages and lymphocytes. In pulmonary sarcoidosis, T-bet upregulation is associated with changes in expression of IFN-&ggr;, CXCR3 and chemokines/receptors involved in the pathogenesis of sarcoidosis, which suggests a role for T-bet in this Th1 disease, including modulation of some sarcoidosis-associated genes.

[1]  B. Beghé,et al.  Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. , 2005, American journal of respiratory and critical care medicine.

[2]  R. D. du Bois,et al.  Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis , 2009, Clinical and experimental immunology.

[3]  C. Agostini,et al.  Immunology and pathophysiology , 2005 .

[4]  H. Stein,et al.  T‐bet expression patterns in coeliac disease, cryptic and overt enteropathy‐type T‐cell lymphoma , 2005, Histopathology.

[5]  R. D. du Bois,et al.  PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells , 2008, BMC Molecular Biology.

[6]  K. Beima,et al.  T-bet's Ability To Regulate Individual Target Genes Requires the Conserved T-Box Domain To Recruit Histone Methyltransferase Activity and a Separate Family Member-Specific Transactivation Domain , 2007, Molecular and Cellular Biology.

[7]  M. Mirabella,et al.  Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease. , 2008, Human immunology.

[8]  A. Prasse,et al.  Sarcoidosis--immunopathogenetic concepts. , 2007, Seminars in respiratory and critical care medicine.

[9]  R. D. du Bois,et al.  CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis. , 2002, Immunology letters.

[10]  R. Zambello,et al.  Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. , 1996, Journal of immunology.

[11]  J. Hagman,et al.  Temporal Dissection of T-bet Functions1 , 2007, The Journal of Immunology.

[12]  D. Cosman,et al.  IL‐15, a novel T cell growth factor that shares activities and receptor components with IL‐2 , 1995, Journal of leukocyte biology.

[13]  J. Grunewald,et al.  Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis , 2003, Journal of internal medicine.

[14]  陶仲为 Sarcoidosis , 2009 .

[15]  Laurie H Glimcher,et al.  A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.

[16]  M. Schlaak,et al.  Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis , 2003, European Respiratory Journal.

[17]  R. Elashoff,et al.  CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis , 2009, European Respiratory Journal.

[18]  R. D. du Bois,et al.  CC and C chemokine expression in pulmonary sarcoidosis , 2002, European Respiratory Journal.

[19]  R. Govindarajan,et al.  Pulmonary sarcoidosis. , 1985, The Journal of the Association of Physicians of India.

[20]  T. Huang,et al.  T-bet Binding to Newly Identified Target Gene Promoters Is Cell Type-independent but Results in Variable Context-dependent Functional Effects*♦ , 2006, Journal of Biological Chemistry.

[21]  S. Sone,et al.  CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages , 2007, Clinical and experimental immunology.

[22]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[23]  R. Crystal,et al.  Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. , 1985, The Journal of clinical investigation.

[24]  M. Chilosi,et al.  Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. , 1998, Journal of immunology.

[25]  D. Schust,et al.  Induction of Maternal Tolerance to Fetal Alloantigens by RANTES Production , 2006, American journal of reproductive immunology.

[26]  R. D. du Bois,et al.  The source and role of RANTES in interstitial lung disease. , 1997, The European respiratory journal.

[27]  Activation of the Cholinergic Anti-Inflammatory System by Nicotine Attenuates Neuroinflammation via Suppression of Th1 and Th17 Responses , 2009, The Journal of Immunology.

[28]  M. Sopori,et al.  Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.

[29]  S. Holdsworth,et al.  T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. , 2008, Journal of the American Society of Nephrology : JASN.

[30]  Toshifumi Hibi,et al.  T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn’s disease , 2004, Gut.

[31]  P. Spagnolo,et al.  C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. , 2003, American journal of respiratory and critical care medicine.

[32]  N. Sato,et al.  Enhanced mRNA expression of Th1 cytokines and IL-12 in active pulmonary sarcoidosis. , 2000, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[33]  C. Szeto,et al.  Decreased T‐bet expression and changes in chemokine levels in adults with asthma , 2007, Clinical and experimental immunology.